Director's Dealings

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen, Germany (pta031/18.02.2021/16:52) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated 
a)NameDr. Foguet Montserrat
2 Reason for the notification 
a)Position/statusOther person discharging managerial responsibilities
Senior Vice President, Regulatory Affairs and Production;
b)Initial notification 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
a)NameBiofrontera AG
b)LEI391200D6GFSVFGFQTL13
4 Details of the transaction(s) 
a)Description of the financial instrument, type of instrumentShare
 Identification codeDE0006046113
b)Nature of the transactionAnother
 Subscription of shares as part of a rights capital measure
c)Price(s)Volume(s)
 2.75 EUR57,598.75 EUR
d)Aggregated priceAggregated volume
 2.75 EUR57,598.75 EUR
e)Date of the transaction18.02.2021 UTC+1
f)Place of the transactionOutside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20210218031 ]

Directors' Dealings archive

2020

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen, Germany (pta031/18.02.2021/16:52) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated 
a)NameDr. Foguet Montserrat
2 Reason for the notification 
a)Position/statusOther person discharging managerial responsibilities
Senior Vice President, Regulatory Affairs and Production;
b)Initial notification 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
a)NameBiofrontera AG
b)LEI391200D6GFSVFGFQTL13
4 Details of the transaction(s) 
a)Description of the financial instrument, type of instrumentShare
 Identification codeDE0006046113
b)Nature of the transactionAnother
 Subscription of shares as part of a rights capital measure
c)Price(s)Volume(s)
 2.75 EUR57,598.75 EUR
d)Aggregated priceAggregated volume
 2.75 EUR57,598.75 EUR
e)Date of the transaction18.02.2021 UTC+1
f)Place of the transactionOutside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20210218031 ]